Effects of age and comorbidity on treatment and survival of patients with muscle-invasive bladder cancer

International Journal of Cancer

Volumn 135, Issue 4, 2014, Pages 905-912

  Goossens Laan, Catharina A ^a   Leliveld, Anna M ^a   Verhoeven, Rob H A ^b   Kil, Paul J M ^c   De Bock, Geertruida H ^a   Hulshof, Maarten C C M ^d   De Jong, Igle J ^a   Coebergh, Jan Willem W ^b,e  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b The Netherlands   (Netherlands)

^c Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

comorbidity; cystectomy; muscle invasive bladder cancer; population based; survival

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CENTRALIZATION; COMORBIDITY; CONTROLLED STUDY; CYSTECTOMY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE INVASIVE BLADDER CANCER; NETHERLANDS; OVERALL SURVIVAL; POPULATION RESEARCH; PREDICTOR VARIABLE; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; SOCIAL STATUS;

COMORBIDITY; CYSTECTOMY; MUSCLE-INVASIVE BLADDER CANCER; POPULATION-BASED; SURVIVAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COMORBIDITY; CYSTECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUSCLE, SMOOTH; NEOPLASM INVASIVENESS; NETHERLANDS; ODDS RATIO; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SOCIAL CLASS; TREATMENT OUTCOME; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84902294296     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28716     Document Type: Article

References (30)

1. Olden TE, Schols JM, Hamers JP, et al. Predicting the need for end-of-life care for elderly cancer patients: findings from a Dutch regional cancer registry database. Eur J Cancer Care 2012; 21: 477-84.
2. Janssen-Heijnen ML, Houterman S, Lemmens VE, et al. Prognostic impact of increasing age and comorbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol 2005; 55: 231-40.
3. Clark PE, Stein JP, Groshen SG, et al. Radical cystectomy in the elderly: comparison of survival between younger and older patients. Cancer 2005; 103: 546-52.
4. Fisher MB, Svatek RS, Hegarty PK, et al. Cardiac history and risk of post-cystectomy cardiac complications. Urology 2009; 74: 1085-89.
5. Goossens-Laan CA, Gooiker GA, van Gijn W, et al. A systematic review and meta-analysis of the relationship between hospital/surgeon volume and outcome for radical cystectomy: an update for the ongoing debate. Eur Urol 2011; 59: 775-83.
6. Stenzl A, Cowan NC, De SM, et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 2011; 59: 1009-18.
7. Clark PE,. Bladder cancer. Curr Opin Oncol 2007; 19: 241-47.
8. Chang SS, Alberts G, Cookson MS, et al. Radical cystectomy is safe in elderly patients at high risk. J Urol 2001; 166: 938-41.
9. Hollenbeck BK, Miller DC, Taub D, et al. Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. Urology 2004; 64: 292-97.
10. Weizer AZ, Montie JE, Lee CT,. Aggressive management of elderly patients with muscle-invasive bladder cancer. Nat Clin Pract Urol 2006; 3: 346-47.
11. Basso U, Bassi P, Sava T, et al. Management of muscle-invasive bladder cancer in the elderly. Expert Rev Anticancer Ther 2004; 4: 1017-35.
12. Chamie K, Hu B, Vere White RW, et al. Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians? BJU Int 2008; 102: 284-90.
13. Farnham SB, Cookson MS, Alberts G, et al. Benefit of radical cystectomy in the elderly patient with significant co-morbidities. Urol Oncol 2004; 22: 178-81.
14. Lance RS, Grossman HB,. Cystectomy in the elderly. Semin Urol Oncol 2001; 19: 51-55.
15. Konety BR,. Sickness and survival in bladder cancer: is comorbidity the crystal ball? Eur Urol 2008; 53: 465-67.
16. Koning CC, Blank LE, Koedooder C, et al. Brachytherapy after external beam radiotherapy and limited surgery preserves bladders for patients with solitary pT1-pT3 bladder tumors. Ann Oncol 2012; 23: 2948-45.
17. Tran E, Souhami L, Tanguay S, et al. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer. Am J Clin Oncol 2009; 32: 333-37.
18. James ND, Hussain SA, Hall E, et al. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med 2012; 366: 1477-88.
19. Aarts MJ, Koldewijn EL, Poortmans PM, et al. The Impact of socioeconomic status on prostate cancer treatment and survival in The Southern Netherlands. Urology 2013; 81: 593-99.
20. Schouten LJ, Hoppener P, van den Brandt PA, et al. Completeness of cancer registration in Limburg, The Netherlands. Int J Epidemiol 1993; 22: 369-76.
21. Louwman WJ, Aarts MJ, Houterman S, et al. A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status. BrJ Cancer 2010; 103: 1742-48.
22. Prout GR, Marshall VF,. The prognosis with untreated bladder tumors. Cancer 1956; 9: 551-58.
23. Prout GR Jr, Wesley MN, Yancik R, et al. Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Cancer 2005; 15: 1638-47.
24. Megwalu II, Vlahiotis A, Radwan M, et al. Prognostic impact of comorbidity in patients with bladder cancer. Eur Urol 2008; 53: 581-89.
25. Koppie TM, Serio AM, Vickers AJ, et al. Age adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer 2008; 112: 2384-92.
26. Lughezzani G, Sun M, Shariat SF, et al. A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer. Cancer 2011; 117: 103-09.
27. Extermann M,. Studies of comprehensive geriatric assessment in patients with cancer. Cancer Control 2003; 10: 463-68.
28. Kristjansson SR, Nesbakken A, Jordhøy MS, et al. Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: a prospective observational cohort study. Crit Rev Oncol Hematol 2010; 76: 208-17.
29. Goossens-Laan CA, Visser O, Hulshof MC, et al. Survival after treatment for carcinoma invading bladder muscle: a Dutch population-based study on the impact of hospital volume. BJU Int 2012; 110: 226-32.
30. Shah BR, Laupacis A, Hux JE, et al. Propensity score methods gave similar results to traditional regression modeling in observational studies: a systematic review. J Clin Epidemiol 2005; 58: 550-59.